Complicated Urinary Tract Infections: Clinical Trials

2 trials for Complicated Urinary Tract Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 withdrawn. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Withdrawn 1

Follow Complicated Urinary Tract Infections: new trials by email Literature Review of Complicated Urinary Tract Infections trials Research Report on Complicated Urinary Tract Infections

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
LYS228 PK, Clinical Response, Safety and Tolerability in Patients With Complicated Urinary Tract Infection (cUTI)
LYS228, Standard of care therapy - Complicated Urinary Tract Infections
Phase 2WithdrawnNovartis Pharmaceuticals2018-10-192018-10-26
Evaluation of Safety, Pharmacokinetics and Efficacy of Ceftazidime and Avibactam (CAZ-AVI ) Compared With Cefepime in Children From 3 Months to Less Than 18 Years of Age With Complicated Urinary Tract Infections (cUTIs)
Ceftazidime -avibactam, Cefepime - Complicated Urinary Tract Infections
Phase 2CompletedPfizer972015-09-242018-07-11

Narrower conditions

Urinary Tract Infections (1)

Broader conditions

Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Infections (1)  ·  Male Urogenital Diseases (1)  ·  Urogenital Diseases (1)  ·  Urologic Diseases (1)

Interventions

Cefepime (1)  ·  avibactam, ceftazidime drug combination (1)

Sponsors

Novartis Pharmaceuticals (1)  ·  Pfizer (1)

Countries

Greece (2)  ·  United States (2)  ·  Czechia (1)  ·  Denmark (1)  ·  Hungary (1)  ·  Poland (1)  ·  Romania (1)  ·  Russia (1)  ·  Taiwan (1)  ·  Turkey (Türkiye) (1)

Results publications

PMID 30061293, PMID 31335570, PMID 34687548

NIH funding

2014 (1)